Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1

Status

Withdrawn 1Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Anorexia 4Weight Loss 2Neoplasms 2Cachexia 2Sleep Initiation and Maintenance Disorders 1Depression 1Carcinoma, Non-Small-Cell Lung 1Body Weight 1Anorexia Nervosa with Significantly Low Body Weight 1

Interventions

Mirtazapine 4Megestrol Acetate 4nabiximols 1anamorelin 1Watchful Waiting 1Thalidomide 1Olanzapine 1Observation 1Megestrol 1Infliximab 1Gemcitabine 1Flurandrenolone 1EOM613 1Dronabinol 1Dexamethasone 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Anorexia × Mirtazapine × Clear all
NCT00488072 2026-01-26

Effects of Mirtazapine on Appetite in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
98 enrolled

Anorexia, Sleep Initiation and Maintenance Disorders, Weight Loss

NCT03283488 2023-07-07

Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.

University of Sao Paulo

Phase 2 Completed
52 enrolled

Anorexia, Cachexia, Neoplasms

NCT05380479 2022-05-18

Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2 Unknown
80 enrolled

Anorexia, Cachexia, Neoplasms

NCT01501396 2014-02-03

Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite

Washington University School of Medicine

Phase 2 Withdrawn

Anorexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡